Company Mba Pharma Innovation Srl with Fiscal Code 32413765
recorded a turnover of 2024 of
4.949.669,
with a net profit of
1.072.223
and having an average number of employees of
11.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Mba Pharma Innovation Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
26.902
182.165
300.400
895.253
788.806
3.295.700
3.089.566
3.120.709
4.467.618
4.949.669
Total Income - EUR
26.902
183.564
358.399
975.651
820.676
3.570.784
3.390.020
3.295.057
4.663.227
5.084.530
Total Expenses - EUR
19.514
145.533
345.270
761.885
728.465
2.554.326
2.346.254
2.411.820
3.525.890
3.839.187
Gross Profit/Loss - EUR
7.388
38.031
13.130
213.766
92.211
1.016.458
1.043.766
883.237
1.137.337
1.245.343
Net Profit/Loss - EUR
6.581
36.139
8.247
203.955
84.569
895.924
917.650
766.791
981.130
1.072.223
Employees
2
3
3
3
4
4
6
7
10
11
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 11.4%, from 4.467.618 euro in the year 2023, to 4.949.669 euro in 2024.
The Net Profit increased by 96.576 euro, from 981.130 euro in 2023, to 1.072.223 in the last year.
Check the financial reports for the company - Mba Pharma Innovation Srl
Financial Rating - MBA PHARMA INNOVATION SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Mba Pharma Innovation Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Mba Pharma Innovation Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Mba Pharma Innovation Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mba Pharma Innovation Srl - CUI 32413765
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
50
484
81.355
94.646
38.796
154.200
279.318
268.470
309.098
252.598
Current Assets
18.804
46.482
130.398
439.384
426.398
1.146.161
1.137.434
2.228.940
2.785.679
2.712.238
Inventories
9.325
3.505
42.588
91.974
134.619
42.395
76.677
328.177
824.082
893.917
Receivables
1.630
6.858
14.386
68.451
65.031
438.231
556.562
1.329.626
1.652.788
1.569.823
Cash
7.849
36.119
73.424
278.960
226.748
665.535
504.195
571.138
308.809
248.498
Shareholders Funds
6.626
40.359
47.495
250.578
250.328
897.038
1.189.629
1.732.046
1.851.010
2.052.511
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
12.229
6.608
164.259
283.411
214.479
402.955
226.762
383.780
1.243.768
912.325
Income in Advance
0
0
0
41
388
369
361
381.585
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
2.712.238 euro in 2024 which includes Inventories of
893.917 euro, Receivables of
1.569.823 euro and cash availability of
248.498 euro.
The company's Equity was valued at
2.052.511 euro, while total Liabilities amounted to
912.325 euro.
Equity increased by 211.846 euro, from 1.851.010 euro in 2023, to 2.052.511 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mba Pharma Innovation Srl